Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models
暂无分享,去创建一个
Andrzej Cichocki | Tatsuya Yokota | Junhua Li | Koichi Ogawa | Peter Jurica | Zbigniew R Struzik | Yuji Takahara | Masahito Horiuchi | Shuichi Hiroyama | Kohei Nishitomi | Minoru Hasegawa
[1] Maria E. Zuniga,et al. A Pilot Project , 2016 .
[2] T. Robbins,et al. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. , 2009, Annual review of neuroscience.
[3] K. Okamoto,et al. Development of a strain of spontaneously hypertensive rats. , 1963, Japanese circulation journal.
[4] Sandra K Loo,et al. EEG correlates of methylphenidate response among children with ADHD: a preliminary report , 1999, Biological Psychiatry.
[5] S. Makeig,et al. Clinical Utility of EEG in Attention-Deficit/Hyperactivity Disorder: A Research Update , 2012, Neurotherapeutics.
[6] Terje Sagvolden,et al. Behavioral and Brain Functions , 2006 .
[7] Julian Elliott,et al. Attentional and Executive Function Behaviours in Children with Poor Working Memory. , 2008 .
[8] J. McCracken,et al. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[9] R. Chabot,et al. Behavioral and Electrophysiologic Predictors of Treatment Response to Stimulants in Children with Attention Disorders , 1999, Journal of child neurology.
[10] Masato Umehara,et al. Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats. , 2013, European journal of pharmacology.
[11] M. Sherman,et al. A Preliminary Report , 1953 .
[12] E. John,et al. Quantitative Electroencephalography in OCD Patients Treated with Paroxetine , 2003, Clinical EEG.
[13] Joseph Biederman,et al. Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder , 1999, Biological Psychiatry.
[14] B. Amini,et al. DIFFERENTIAL LOCOMOTOR RESPONSES IN MALE RATS FROM THREE STRAINS TO ACUTE METHYLPHENIDATE , 2004, The International journal of neuroscience.
[15] Vincent J Monastra,et al. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach. , 2005, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[16] Mark D'Esposito,et al. Neurology of Cognitive and Behavioral Disorders , 2001 .
[17] Trevor W. Robbins,et al. Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex , 2000, The Journal of Neuroscience.
[18] Vincent J Monastra,et al. Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: an initial validation study. , 1999, Neuropsychology.
[19] E. John,et al. Electrophysiological subtypes of psychotic states , 2007, Acta psychiatrica Scandinavica.
[20] Andy H. Choi,et al. Current Perspectives , 2013, Journal of dental research.
[21] T. Banaschewski,et al. Normalisation of frontal theta activity following methylphenidate treatment in adult attention-deficit/hyperactivity disorder , 2015, European Neuropsychopharmacology.
[22] F Xavier Castellanos,et al. Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder , 1996, Neuropsychopharmacology.
[23] D. Viggiano,et al. Involvement of Norepinephrine in the Control of Activity and Attentive Processes in Animal Models of Attention Deficit Hyperactivity Disorder , 2004, Neural plasticity.
[24] J. Bizot,et al. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats , 2007, Psychopharmacology.
[25] Mehdi Farshbaf,et al. Rodent Models of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.
[26] Michael T. Bardo,et al. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in Spontaneously Hypertensive, Wistar–Kyoto and Sprague–Dawley rats , 2011, Brain Research.
[27] Robert J. Barry,et al. Effects of stimulant medications on the EEG of girls with Attention-Deficit/Hyperactivity Disorder , 2002, Clinical Neurophysiology.
[28] B. Waterhouse,et al. Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons , 2012, Biological Psychiatry.
[29] Toshio Matsuda,et al. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice , 2010, Journal of neurochemistry.
[30] Philip Asherson,et al. The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD , 2014, Brain and Cognition.
[31] F. Castellanos,et al. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.
[32] L. Dwoskin,et al. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood. , 2013, Biochemical pharmacology.
[33] E. John,et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder , 1993, Psychiatry Research: Neuroimaging.
[34] E. Redei,et al. Selectively bred Wistar–Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants , 2003, Molecular Psychiatry.
[35] Rakesh Jain,et al. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder , 2009, Psychiatry Research.
[36] Knut A Hestad,et al. Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test , 2014, Neuropsychiatric disease and treatment.
[37] L. Dwoskin,et al. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. , 2008, Behavioral neuroscience.
[38] J. Biederman,et al. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. , 1991, The American journal of psychiatry.
[39] Robert J. Barry,et al. Coherence in children with AD/HD and excess alpha power in their EEG , 2016, Clinical Neurophysiology.
[40] J. Wickens,et al. Neurobiology of ADHD , 2009, Neuropharmacology.
[41] J. Lubar,et al. Methylphenidate effects on EEG, behavior, and performance in boys with ADHD. , 1998, Pediatric neurology.
[42] Eleanor J. Dommett,et al. Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat , 2013, Behavioural Brain Research.
[43] Vasily Vorobyov,et al. Cortical and hippocampal EEG effects of neurotransmitter agonists in spontaneously hypertensive vs. kainate-treated rats , 2011, Brain Research.
[44] M. Genton,et al. Functional Boxplots , 2011 .
[45] Jeffrey C. Glennon,et al. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder , 2007, Neuroscience & Biobehavioral Reviews.
[46] Rodney J Croft,et al. EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder , 2002, Clinical Neurophysiology.
[47] E. John,et al. The neurophysiology of attention-deficit/hyperactivity disorder. , 2005, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[48] O. Pomerleau,et al. Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. , 1997, The Journal of nervous and mental disease.
[49] Richard N Re,et al. Research Update , 2009, The Ochsner journal.
[50] B. Langen,et al. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists , 2011, Attention deficit and hyperactivity disorders.
[51] L. Dwoskin,et al. Adolescent Atomoxetine Treatment in a Rodent Model of ADHD: Effects on Cocaine Self-Administration and Dopamine Transporters in Frontostriatal Regions , 2013, Neuropsychopharmacology.
[52] Berend Olivier,et al. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder , 2006, Pharmacology Biochemistry and Behavior.
[53] Robert Isenhart,et al. The quantified EEG characteristics of responders and non-responders to long-term treatment with atomoxetine in children with attention deficit hyperactivity disorders. , 2016, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[54] J. Lubar,et al. Methylphenidate effects on global and complex measures of EEG. , 1999, Pediatric neurology.
[55] E I Moser,et al. Component analyses differentiate between exploratory behaviour of spontaneously hypertensive rats and Wistar Kyoto rats in a two-compartment free-exploration open field. , 1988, Scandinavian journal of psychology.
[56] S. Knardahl,et al. Open-field behavior of spontaneously hypertensive rats. , 1979, Behavioral and neural biology.
[57] Tatsuji Iga,et al. Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats , 1996, Psychopharmacology.
[58] Rodney J Croft,et al. EEG activity in girls with attention-deficit/hyperactivity disorder , 2003, Clinical Neurophysiology.
[59] C. F. Schaefer,et al. Lifelong hyperarousal in the spontaneously hypertensive rat indicated by operant behavior , 1978, The Pavlovian journal of biological science.
[60] W. Woolverton,et al. Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine. , 2004, Drug and alcohol dependence.
[61] Rakesh Jain,et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study , 2009, Psychiatry Research.
[62] M. D’Esposito,et al. FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY OF THE FFECTS OF PERGOLIDE , A DOPAMINE RECEPTOR AGONIST , N COMPONENT PROCESSES OF WORKING MEMORY , 2006 .
[63] Federico Sanabria,et al. Characterizing operant hyperactivity in the Spontaneously Hypertensive Rat , 2012, Behavioral and Brain Functions.
[64] Robert J. Barry,et al. Acute atomoxetine effects on the EEG of children with Attention-Deficit/Hyperactivity Disorder , 2009, Neuropharmacology.
[65] M. van den Buuse,et al. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. , 1989, The Journal of pharmacology and experimental therapeutics.
[66] Julián J. González,et al. Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility , 2015, Neuropsychiatric disease and treatment.
[67] Agatha Lenartowicz,et al. Use of EEG to Diagnose ADHD , 2014, Current Psychiatry Reports.
[68] M. Moser,et al. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. , 1990, Behavioral and neural biology.
[69] M. Gerlach,et al. Peer-reviewed reports on all topics relevant to attention-deficit/hyperactivity disorder , 2009, Attention deficit and hyperactivity disorders.
[70] M. Reilly,et al. Impulsive choice in a rodent model of attention-deficit/hyperactivity disorder , 2008, Behavioural Brain Research.
[71] C. F. Schaefer,et al. Behavioral hyperreactivity in the spontaneously hypertensive rat compared to its normotensive progenitor , 1978, The Pavlovian journal of biological science.
[72] Seol-Heui Han,et al. A Simple Behavioral Paradigm to Measure Impulsive Behavior in an Animal Model of Attention Deficit Hyperactivity Disorder (ADHD) of the Spontaneously Hypertensive Rats , 2012, Biomolecules & therapeutics.
[73] Alexander S Korb,et al. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. , 2014, Journal of psychiatric research.
[74] JaneR . Taylor,et al. Supranormal Stimulation of D1 Dopamine Receptors in the Rodent Prefrontal Cortex Impairs Spatial Working Memory Performance , 1997, The Journal of Neuroscience.
[75] S. Faraone,et al. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type , 2010, Neuroscience.
[76] Antonio Caprioli,et al. The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations , 2003, Neuroscience & Biobehavioral Reviews.
[77] J. Lubar,et al. The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies. , 2001, Neuropsychology.